160 related articles for article (PubMed ID: 26609139)
1. MicroRNA Responses to the Genotoxic Carcinogens Aflatoxin B1 and Benzo[a]pyrene in Human HepaRG Cells.
Marrone AK; Tryndyak V; Beland FA; Pogribny IP
Toxicol Sci; 2016 Feb; 149(2):496-502. PubMed ID: 26609139
[TBL] [Abstract][Full Text] [Related]
2. Effect of aflatoxin B
Tryndyak V; Kindrat I; Dreval K; Churchwell MI; Beland FA; Pogribny IP
Food Chem Toxicol; 2018 Nov; 121():214-223. PubMed ID: 30157460
[TBL] [Abstract][Full Text] [Related]
3. Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds.
Josse R; Dumont J; Fautrel A; Robin MA; Guillouzo A
Toxicol Appl Pharmacol; 2012 Jan; 258(2):176-87. PubMed ID: 22100608
[TBL] [Abstract][Full Text] [Related]
4. Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes.
Jetten MJ; Kleinjans JC; Claessen SM; Chesné C; van Delft JH
Toxicol In Vitro; 2013 Oct; 27(7):2031-40. PubMed ID: 23911569
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the generation of genotoxic and cytotoxic metabolites of benzo[a]pyrene, aflatoxin B1, naphthalene and tamoxifen using human liver microsomes and human lymphocytes.
Wilson AS; Tingle MD; Kelly MD; Park BK
Hum Exp Toxicol; 1995 Jun; 14(6):507-15. PubMed ID: 8519528
[TBL] [Abstract][Full Text] [Related]
6. Identification of essential transcription factors for adequate DNA damage response after benzo(a)pyrene and aflatoxin B1 exposure by combining transcriptomics with functional genomics.
Smit E; Souza T; Jennen DGJ; Kleinjans JCS; van den Beucken T
Toxicology; 2017 Sep; 390():74-82. PubMed ID: 28882572
[TBL] [Abstract][Full Text] [Related]
7. Effects of aflatoxin B1 on the hepatic microsomal mixed function oxidase system during phenobarbital and benzo(a)pyrene treatment in chickens.
Govindwar SP; Adav SS
Vet Hum Toxicol; 1999 Aug; 41(4):210-2. PubMed ID: 10434373
[TBL] [Abstract][Full Text] [Related]
8. Evaluating microRNA profiles reveals discriminative responses following genotoxic or non-genotoxic carcinogen exposure in primary mouse hepatocytes.
Rieswijk L; Brauers KJ; Coonen ML; van Breda SG; Jennen DG; Kleinjans JC
Mutagenesis; 2015 Nov; 30(6):771-84. PubMed ID: 25976910
[TBL] [Abstract][Full Text] [Related]
9. Gene expression and cytosine DNA methylation alterations in induced pluripotent stem-cell-derived human hepatocytes treated with low doses of chemical carcinogens.
Tryndyak V; Borowa-Mazgaj B; Beland FA; Pogribny IP
Arch Toxicol; 2019 Nov; 93(11):3335-3344. PubMed ID: 31555880
[TBL] [Abstract][Full Text] [Related]
10. Profound changes in miRNA expression during cancer initiation by aflatoxin B
Livingstone MC; Johnson NM; Roebuck BD; Kensler TW; Groopman JD
Mol Carcinog; 2017 Nov; 56(11):2382-2390. PubMed ID: 28218475
[TBL] [Abstract][Full Text] [Related]
11. Comparative assessment of DNA adduct formation, Salmonella mutagenicity, and chromosome aberration assays as short-term tests for DNA damage.
Choi MJ; Lee JW; Lee BM
J Toxicol Environ Health; 1996 Oct; 49(3):271-84. PubMed ID: 8876654
[TBL] [Abstract][Full Text] [Related]
12. Skin tumorigenic potential of aflatoxin B1 in mice.
Rastogi S; Dogra RK; Khanna SK; Das M
Food Chem Toxicol; 2006 May; 44(5):670-7. PubMed ID: 16298033
[TBL] [Abstract][Full Text] [Related]
13. Benzo[a]pyrene-induced transcriptomic responses in primary hepatocytes and in vivo liver: toxicokinetics is essential for in vivo-in vitro comparisons.
van Kesteren PC; Zwart PE; Schaap MM; Pronk TE; van Herwijnen MH; Kleinjans JC; Bokkers BG; Godschalk RW; Zeilmaker MJ; van Steeg H; Luijten M
Arch Toxicol; 2013 Mar; 87(3):505-15. PubMed ID: 23052197
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by diacylmethane derivatives of mutagenicity in Salmonella typhimurium and tRNA-binding of chemical carcinogens.
Wang CY; Lee MS; Zukowski K
Mutat Res; 1991 Mar; 262(3):189-93. PubMed ID: 1900573
[TBL] [Abstract][Full Text] [Related]
15. High susceptibility to aflatoxin B1 and benzo[a]pyrene of BALB3T3 A31-1-1 cells expressing monkey CYP1A1.
Itoh S; Tagawa S; Sawada M; Kamataki T
J Toxicol Sci; 1993 Aug; 18(3):207-10. PubMed ID: 8246314
[TBL] [Abstract][Full Text] [Related]
16. Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma.
Rieswijk L; Claessen SM; Bekers O; van Herwijnen M; Theunissen DH; Jennen DG; de Kok TM; Kleinjans JC; van Breda SG
Toxicology; 2016 Mar; 350-352():31-9. PubMed ID: 27153756
[TBL] [Abstract][Full Text] [Related]
17. Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification.
Jennen DG; Magkoufopoulou C; Ketelslegers HB; van Herwijnen MH; Kleinjans JC; van Delft JH
Toxicol Sci; 2010 May; 115(1):66-79. PubMed ID: 20106945
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the genotoxic potential of indirect chemical mutagens in HepaRG cells by the comet and the cytokinesis-block micronucleus assays.
Le Hegarat L; Dumont J; Josse R; Huet S; Lanceleur R; Mourot A; Poul JM; Guguen-Guillouzo C; Guillouzo A; Fessard V
Mutagenesis; 2010 Nov; 25(6):555-60. PubMed ID: 20675360
[TBL] [Abstract][Full Text] [Related]
19. Some aspects of the human carcinogenicity of aflatoxin B1 and 3, 4 benz [a] pyrene.
Akintonwa DA
Int J Epidemiol; 1982 Sep; 11(3):293-4. PubMed ID: 6290406
[No Abstract] [Full Text] [Related]
20. Geno- and cytotoxicity of nitrosamines, aflatoxin B1, and benzo[a]-pyrene in continuous cultures of rat hepatoma cells.
Loquet C; Wiebel FJ
Carcinogenesis; 1982; 3(10):1213-8. PubMed ID: 6293736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
